Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy.
Journal: Cancer research communications
Published: May 05, 2025
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures.
Journal: The Journal of clinical investigation
Published: March 17, 2025
Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade.
Journal: Journal for immunotherapy of cancer
Published: October 07, 2024
Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 10, 2024
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors.
Journal: Nature communications
Published: May 14, 2024
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 20, 2023
Management of Prosthetic Mitral Valve Infective Endocarditis in a Patient With Congenital Heart Disease.
Journal: JACC. Case reports
Published: December 18, 2023
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures.
Journal: The Journal of clinical investigation
Published: November 20, 2023
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Journal: The oncologist
Published: September 09, 2023
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma.
Journal: Cancer research communications
Published: February 05, 2023
Post-operative ctDNA monitoring in stage I colon cancer: A case report.
Journal: Frontiers in oncology
Published: October 20, 2022
Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: November 02, 2021
Last Updated: 09/26/2026